Marcin Frąckiewicz, Author at TechStock²

NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Rockets to $5 Trillion Valuation – AI Frenzy Fuels Record Highs

Nvidia’s Santa Clara campus (headquarters). The company’s stock hit record highs this week as AI chip demand exploded, powering Nvidia to a historic $5 trillion market value reuters.com reuters.com. Record Highs and Stock Performance Nvidia shares extended a remarkable run

30 October 2025

Chinese EV Tsunami Shakes German Auto Industry: BYD’s 30% Profit Crash and ‘Electrobomber’ Fears

BYD’s Earnings Dive amid Fierce Price War BYD’s October 2025 report shocked investors: third-quarter profit plunged to ¥7.8 billion, down almost 33% from a year ago de.investing.com. CEO Wang Chuanfu has slashed prices across BYD’s model range to fend off competition,

30 October 2025

Automotive Industry · China-Germany Relations · Electric Vehicles · Industry Disruption · Market Trends · NASDAQ:TSLA

Tesla Stock Surges on Record Q3 Sales – Can It Keep Climbing?

Recent Trading and Market Context Tesla Inc. (NASDAQ: TSLA) shares have been trading near the top of their 52-week range amid the late-October market rally. After rising to new highs earlier in October (briefly touching the mid-$450s on Oct. 6), the

30 October 2025

Electric Vehicles · Financial News · Investing · NASDAQ:TSLA · Stock Market · Tesla

BYD’s European EV Invasion – Boom in Sales but Stock Takes a Hit

BYD Stock Plunges 30% on Profit Slump – Is the EV Price War to Blame?

BYD Shares: Price and Recent Moves BYD’s stock has experienced a sharp correction in recent months. In early 2025 the Hong Kong-listed shares hit record highs (above HK$150 in May), but by late October they traded near HK$104 reuters.com –

30 October 2025

Automotive Industry · Company Analysis · Electric Vehicles · Investment News · Stock Market

Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Bidding War Sends Metsera Shares Higher Metsera’s share price has been on a roller-coaster amid takeover speculation. In late September, Pfizer agreed to buy Metsera for $47.50 per share in cash (about $4.9B) plus up to $22.50 in contingent payments

30 October 2025

Business · Investing · Mergers & Acquisitions · NASDAQ:MTSR · NYSE:NVO · NYSE:PFE · Pharma News · Stock Market

Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen Inc. (Nasdaq: BIIB) is a leading neuroscience biotech known for multiple sclerosis and rare-disease therapies ts2.tech. On Oct. 30, 2025 the stock dipped after a mixed earnings release. The company beat Q3 expectations – adjusted EPS $4.81 vs. $3.88

30 October 2025

Biotech News · Earnings Reports · Financial Updates · Investment Analysis · Stock Market

GLE Stock Skyrockets 50%: Key Facts & What’s Next

Market context: Hong Kong’s stock market has been booming in 2025 (Hang Seng +35% YTD) ts2.tech. GLE’s recent spike (circled) comes against a broad tech rally, but its own financials remain thin. Trading Rundown (Last Few Days) In late Oct

30 October 2025

Company Analysis · Financial News · Investment Strategies · Market Trends · Stock Market

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

CI Stock Price and Recent Trend Cigna’s stock has pulled back modestly in late October after a strong run earlier in the year. According to market data, CI closed at $299.12 on Oct 29, 2025, down about 3% from the

30 October 2025

Earnings Reports · Health Insurance · Investment Analysis · Pharmaceutical Industry · Stock Market

Beauty Rebound: Estée Lauder Soars After Stunning Earnings Surprise

Stock Performance Today Estée Lauder shares jumped in early trading after the earnings release. Reuters data show EL pre-market up ~5% to $102.26 tradingview.com. By midday Oct. 30 the stock was about $97.36, down ~1.4% on the day reuters.com. (Over

30 October 2025

Beauty · Cosmetics · Earnings · Skincare · Stock Market

Hot GDP Surprise Shatters Wall Street’s Rally – Stocks Slide on Fed Jitters (Sept 25, 2025)

Stock Market Rollercoaster: Tech Stocks Tumble After Trump-Xi Trade Truce & Fed’s Hawkish Signals

Market Recap Global stocks wobbled this week on the twin shocks of trade news and monetary policy. In Busan on Oct. 30, Trump met Xi Jinping and touted a deal to trim U.S.–China tariffs, resume Chinese soybean and energy imports,

30 October 2025

Federal Reserve · Investment Strategies · NASDAQ:AAPL · NASDAQ:AMZN · NASDAQ:GOOGL · NASDAQ:META · NASDAQ:MSFT · NASDAQ:NVDA · Stock Market · Tech Stocks · Trade War

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk hijacks Pfizer’s Metsera deal with a $9B bid – obesity-drug war heats up

Novo’s counter-offer details Novo Nordisk’s proposal is unsolicited, meaning Metsera’s board and shareholders will now review it against Pfizer’s agreement. Novo emphasizes that Metsera’s experimental therapies would be “complementary” to its own obesity portfolio reuters.com. According to MarketScreener (Dow Jones

30 October 2025

Biotechnology · Industry News · Mergers & Acquisitions · NYSE:NVO · NYSE:PFE · Obesity Drugs · Pharmaceuticals

Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Merck (MRK) Stock Dips on Earnings Beat — Will Pipeline Boost Spur a Rally?

Merck’s stock price dipped on Oct 30, 2025 even as it delivered a strong third-quarter report. The company posted $17.28 B in Q3 sales and $2.58 adjusted EPS – above analyst forecasts marketscreener.com. Sales of Keytruda, its blockbuster cancer drug, grew

30 October 2025

Earnings Reports · Healthcare Industry · Investment Analysis · NYSE:MRK · Pharmaceuticals · Stock Market